AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Financing secured for the development of cancer vaccines.
2003 OCT 8 - (NewsRx.com & NewsRx.net) -- Therion Biologics Corporation has successfully secured private equity financing totaling $39 million for the advanced clinical development of Panvac-VF and Prostvac-VF, its lead vaccine candidates to treat pancreatic cancer and prostate cancer, respectively.
The company anticipates beginning a phase II trial of Prostvac-VF in prostate cancer in late 2003, followed by the initiation of a phase II trial of Panvac-VF in pancreatic cancer in early 2004.
The funds will also be used to expand Therion's manufacturing capabilities at its newly completed 11,000 square foot manufacturing facility, built to GMP (Good Manufacturing Practice) specifications.
The company is planning to grow its manufacturing and related operations to 25 employees over the next year to support the production of trial- and commercial-sized quantities of its proprietary cancer vaccines.
The financing was led by investor/philanthropist Hans-Werner Hector, one of the founders of SAP AG, a software company. Other participants in the financing ...
- Therion Biologics Corporation Receives FDA Agreement to Initiate Phase III...
- Press release article from: PR Newswire May 24, 2004 700+ words
...PANVAC(TM)-VF, for the treatment of metastatic pancreatic cancer in patients who...trials of PANVAC-VF in advanced pancreatic cancer support moving...clinical trials for pancreatic cancer; and PROSTVAC(R)-VF in Phase II clinical...
- Therion Biologics Corporation Initiates Phase III Clinical Trial With...
- Press release article from: PR Newswire June 21, 2004 700+ words
...patients with advanced pancreatic cancer in whom gemcitabine...receive either PANVAC-VF or control treatment...PANVAC(TM)-VF, currently in a...clinical trial for pancreatic cancer; and PROSTVAC(R)-VF currently in a Phase...
- Therion Completes Phase III Enrollment for PANVAC-VF Pancreatic Cancer Trial;...
- Press release article from: PR Newswire February 10, 2006 700+ words
...clinical trial for PANVAC-VF to treat metastatic pancreatic cancer patients has completed...In addition, PANVAC-VF received Orphan Drug...for the treatment of pancreatic cancer; * PROSTVAC(R)-VF is in Phase II trials...
- Therion's Panvac-VF Misses Endpoint In Pancreatic Cancer.
- Magazine article from: BIOWORLD Today November 3, 2009 700+ words
...Senior Staff Writer The pancreatic cancer community received another...announced that Panvac-VF failed to meet its primary...unlikely that Panvac-VF will be further developed...line treatment for pancreatic cancer, although the company...quarter. While Panvac-VF received the ...
- Clinical trial to study Panvac-VF in advanced pancreatic cancer.
- Newspaper article from: Biotech Business Week June 21, 2004 700+ words
...candidate, Panvac-VF, for the treatment...of metastatic pancreatic cancer in patients...for Panvac-VF. The SPA is...clinical trials in pancreatic cancer patients, as...of Panvac-VF in advanced pancreatic cancer support moving...
- Phase III trial to study PANVAC-VF in advanced pancreatic cancer.
- Newspaper article from: Drug Week July 23, 2004 700+ words
...announced that PANVAC-VF, Therion's lead...treatment of metastatic pancreatic cancer in patients who...Metastatic pancreatic cancer is a devastating...assess PANVAC- VF's impact on patient...patients with advanced pancreatic cancer in whom gemcitabine...either ...
- Researchers Present Results from Studies of Therion's Therapeutic Cancer...
- Press release article from: PR Newswire June 7, 2004 700+ words
...PANVAC(TM)-VF for the treatment of metastatic pancreatic cancer, targeted to begin...early-generation pancreatic cancer vaccine, CEA-VF/TRICOM(TM...evaluate PANVAC-VF, Therion's lead pancreatic cancer vaccine candidate...
- Vaccine shows promise in advanced pancreatic cancer, data shows.
- Newspaper article from: Biotech Business Week July 5, 2004 700+ words
...trial of PANVAC-VF for the treatment of metastatic pancreatic cancer, targeted to begin...early-generation pancreatic cancer vaccine, CEA-VF/TRICOM. The...evaluate PANVAC-VF, Therion's lead pancreatic cancer vaccine candidate...